Key result
Azacytidine prevents glucose-induced Lnc CytB hypermethylation and ameliorates mitochondrial dysfunction in diabetic models.
Why the study?
The molecular mechanism of diabetic retinopathy development remains unclear, and this study investigated the role of DNA methylation in the downregulation of mitochondrial long noncoding RNA cytochrome B (Lnc CytB).
Does azacytidine prevent Lnc CytB DNA hypermethylation and downregulation in models of diabetic retinopathy?
Does azacytidine prevent Lnc CytB DNA hypermethylation and downregulation in models of diabetic retinopathy?
DNA hypermethylation plays a major role in the downregulation of retinal Lnc CytB in diabetes, contributing to impaired mitochondrial homeostasis and diabetic retinopathy.
Hypothesis-generating for Lnc CytB in diabetic retinopathy pathogenesis; leaves open any clinical role pending mechanistic and interventional studies.
Diabetic retinopathy, a microvascular complication of diabetes, is the leading cause of blindness in adults, but the molecular mechanism of its development remains unclear. Retinal mitochondrial DNA is damaged and hypermethylated, and mtDNA-encoded genes are downregulated. Expression of a long noncoding RNA (larger than 200 nucleotides, which does not translate into proteins), encoded by mtDNA, cytochrome B (Lnc CytB ), is also downregulated. This study aims to investigate the role of DNA methylation in the downregulation of Lnc CytB in diabetic retinopathy. Human retinal endothelial cells, incubated in 5 mM (normal) or 20 mM (high) D-glucose, in the presence/absence of Azacytidine (a DNA methyl transferase inhibitor) were analyzed for Lnc CytB DNA methylation by immunoprecipitation and methylation specific PCR techniques, and Lnc CytB transcripts by strand-specific PCR and RNA-FISH. Mitochondrial genomic stability was evaluated by quantifying protective mtDNA nucleoids by SYBR green staining and by flow cytometry, and functional stability by oxygen consumption rate using Seahorse analyzer. Results were confirmed in an in vivo model using retina from diabetic rat. While high glucose elevated 5 mC and the ratio of methylated to unmethylated amplicons at Lnc CytB and downregulated its transcripts, azacytidine prevented Lnc CytB DNA hypermethylation and decrease in its expression. Azacytidine also ameliorated decrease in nucleoids and oxygen consumption rate. Similarly, azacytidine prevented increase in retinal Lnc CytB DNA methylation and decrease in its expression in diabetic rats. Thus, DNA hypermethylation plays a major role in the downregulation of retinal Lnc CytB in diabetes, resulting in impaired mitochondrial homeostasis, and culminating in the development of diabetic retinopathy.
No takes yet. Share an insight, caveat, or question.
Kowluru et al. (2024) studied Diabetic retinopathy. Azacytidine vs. Absence of Azacytidine was evaluated on Lnc CytB DNA methylation and expression. Azacytidine prevented high glucose-induced Lnc CytB DNA hypermethylation and decreased expression in retinal endothelial cells and diabetic rats, ameliorating mitochondrial dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: